Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Democrats Ask Science Board To Weigh In On FDA Budget

This article was originally published in The Tan Sheet

Executive Summary

To solve problems "stemming from years of chronic under-funding," Reps. Henry Waxman and John Dingell are asking for input on FDA's fiscal 2009 appropriation from the agency's Science Board, which recently said funding and other problems threaten FDA's scientific and technological capabilities

You may also be interested in...



Funding Advice From FDA Science Board: Double Total Over Next Five Budgets

FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following four federal budgets

Funding Advice From FDA Science Board: Double Total Over Next Five Budgets

FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following four federal budgets

Funding Advice From FDA Science Board: Double Total Over Next Five Budgets

FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following four federal budgets

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel